Advertisement

Application of isoxanthopterin as a new pterin marker in the differential diagnosis of hyperphenylalaninemia

  • Pei-Zhong Bao
  • Jun Ye
  • Lian-Shu Han
  • Wen-Juan Qiu
  • Hui-Wen Zhang
  • Yong-Guo Yu
  • Jian-Guo Wang
  • Xue-Fan Gu
Original Article
  • 18 Downloads

Abstract

Background

This study aimed to explore the value of applying a new pterin marker (isoxanthopterin) to the traditional urine pterin analysis to reduce the rate of mis-diagnosis of 6-pyruvoyltetrahydropterin synthase deficiency (PTPSD) and improve the accuracy of diagnosis.

Methods

We compared the urine neopterin (N), biopterin (B), isoxanthopterin (Iso), B% and Iso% levels between patients with phenylalanine hydroxylase deficiency and those with PTPSD, and found the most specific pterin biomarkers by ROC analysis. A positive cut-off value of urine pterins was determined. The effect of combined Iso% + B + B% in reducing PTPSD mis-diagnosis was evaluated, and the different urine pterin levels in PTPSD and false PTPSD (FPTPSD) were compared. The concordance of PTPSD diagnosis by the new pterin scheme and gene mutation analysis was determined.

Results

(1) Urinary B, B%, Iso and Iso% were significantly lower in PTPSD than those in phenylalanine hydroxylase-deficiency group (P < 0.01); (2) Iso%, B%, and B were the most specific markers; (3) The positive cut-off values of B, B%, Iso% for PTPSD were < 0.17 mmoL/moLCr, < 5.0%, and < 9.5%, respectively; (4) urinary B + B% + Iso% scheme significantly reduced the false-positive rate of PTPSD compared to traditional ones. The Iso% levels in FPTPSD group were higher than the ones in PTPSD group; (5) an accuracy of diagnosis for PTPSD was increased by 9–19% when Iso% was introduced to urinary pterin scheme.

Conclusions

Iso% is helpful to reduce the rate of misdiagnosis of PTPSD in the diagnosis by urinary pterin analysis for hyperphenylalaninemias and improve the accuracy of diagnosis. This approach is worthy of further development and increased utilization.

Keywords

6-Pyruvoyltetrahydropterin synthase Hyperphenylalaninemia Isoxanthopterin Phenylalanine hydroxylase Pterin 

Notes

Author contributions

PZB contributed to HPLC performance of the samples, statistic analysis of the data, and drafting of the article. JY contributed to conception and design, acquisition and interpretation of data, and participate in drafting of the article. LSH, WJQ, HWZ, XFG contributed to acquisition of the samples and patients’ information. YGY contributed to acquisition of the samples and patients’ information, and the gene verification and analysis for the sample. JGW contributed to the gene verification and analysis for the sample. All authors gave their approval for the final version to be published.

Funding

This study was supported by the National Key Research and Development Program of China (2016YFC0905100 and 2016 YFC901505).

Compliance with ethical standards

Ethical approval

This study was approved by the Ethics Committee of Xinhua Hospital (no. XHEC-D-2018-021).

Conflict of interest

No financial or nonfinancial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.

References

  1. 1.
    Blau N. Phenylketonuria and BH4 deficiencies. 3rd ed. Bremen: UNI-MED; 2016.Google Scholar
  2. 2.
    Ye J, Yang Y, Yu W, Zou H, Jiang J, Yang R, et al. Demographics, diagnosis and treatment of 256 patients with tetrahydrobiopterin deficiency in mainland China: results of a retrospective, multicentre study. J Inherit Metab Dis. 2013;36:893–901.CrossRefGoogle Scholar
  3. 3.
    Opladen T, Hoffmann GF, Blau N. An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia. J Inherit Metab Dis. 2012;35:963–73.CrossRefGoogle Scholar
  4. 4.
    Ye J, Yang Y, Yu W, Zou H, Jiang J, Yang R, et al. Demographics, diagnosis and treatment of 256 patients with tetrahydrobiopterin deficiency in mainland China: results of a retrospective, multicentre study. J Inherit Metab Dis. 2013;36:893–901.CrossRefGoogle Scholar
  5. 5.
    Opladen T, Abu Seda B, Rassi A, Thöny B, Hoffmann GF, Blau N, et al. Diagnosis of tetrahydrobiopterin deficiency using filter paper blood spots: further development of the method and 5 years experience. J Inherit Metab Dis. 2011;34:819–26.CrossRefGoogle Scholar
  6. 6.
    Martín Tornero E, Durán Merás I, Espinosa-Mansilla A. HPLC determination of serum pteridine patternas biomarkers. Talanta. 2014;128:319–26.CrossRefGoogle Scholar
  7. 7.
    Mancha de Llanos A, De Zan MM, Culzoni MJ, Espinosa-Mansilla A, Cañada-Cañada F, Muñoz de la Peña A, et al. Determination of marker pteridines in urine by HPLC with fluorimetric detection and second-order multivariate calibration using MCR-ALS. Anal Bioanal Chem. 2011;399:2123–35.CrossRefGoogle Scholar
  8. 8.
    Burton C, Shi H, Ma Y. Simultaneous detection of six urinary pteridines and creatinine by high-performance liquid chromatography-tandem mass spectrometry for clinical breast cancer detection. Anal Chem. 2013;85:11137–45.CrossRefGoogle Scholar
  9. 9.
    Gamagedara S, Gibbons S, Ma Y. Investigation of urinary pteridine levels as potential biomarkers for noninvasive diagnosis of cancer. Clin Chim Acta. 2011;412:120–8.CrossRefGoogle Scholar
  10. 10.
    Scriver CR. The PAH gene, phenylketonuria, and a paradigm shift. Hum Mutat. 2007;28:831–45.CrossRefGoogle Scholar

Copyright information

© Children's Hospital, Zhejiang University School of Medicine 2018

Authors and Affiliations

  • Pei-Zhong Bao
    • 1
  • Jun Ye
    • 1
  • Lian-Shu Han
    • 1
  • Wen-Juan Qiu
    • 1
  • Hui-Wen Zhang
    • 1
  • Yong-Guo Yu
    • 1
  • Jian-Guo Wang
    • 1
  • Xue-Fan Gu
    • 1
  1. 1.Department of Endocrinology and Genetics, Shanghai Institute of Pediatrics, Xinhua HospitalShanghai Jiaotong University School of MedicineShanghaiChina

Personalised recommendations